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GLUCOCORTICOID---RESPONSIVE HEPATIC CYTOCHROMES P-450 IN THE RAT:
MULTIPLICITY AND DIFFERENTIAL REGULATION

ABSTRACT

A thesis submitted in partial fulfillment of the requirements for the
degree of Doctor of Philosophy at Virginia Commonwealth University.
Keith A. Hostetler
Virginia Commonwealth University
Philip S. Guzelian, M.D., Advisor

The multiplicity of glucocorticoid-responsive hepatic cytochromes
P-450 in the rat was investigated by developing a series of monoclonal
antibody probes directed against purified steroid-inducible isozymes
from the rat (P-450p) and man (HLp).

Two antibodies, termed 1G8 and

13-7-10, showed unique specificity for purified cytochromes P-450 upon
immunoblot analyses.

These antibodies were further characterized in

terms of their reactivity toward proteins in liver microsomes from
untreated and xenobiotic-treated rats.

Three P-450p-related proteins

were identified using 1G8 and 13-7-10 to monitor the expression of
P-450p family subtypes.

In untreated rats, members of this family

exhibited sex-specific expression. Treatment with various chemicals
resulted in differential induction of the 1G8- and 13-7-10-reactive
proteins, demonstrating distinct regulatory features of these
immunochemically-related proteins.

While searching for novel inducers

of the P-450p family, the imidazole antifungal drug clot rimazole was
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found to significantly increase total cytochrome P-450.

Detailed

studies were undertaken to investigate the mechanism by which
clotrimazole and other antifungal drugs induce hepatic cytochrome
P-450.

The effect of treatment of rats with the antifungal drugs

clotrimazole, miconazole, or ketoconazole on the expression of three
distinct P-450 gene families (glucocorticoid-responsive P-450p,
phenobarbital-responsive P-450b/e , and ethanol-responsive P-450j) was
determinded by measuring:
marker substrates,

1) microsomal enzymatic activities with

2) the microsomal content of immunoreactive

cytochromes P-450 with specific antibodies, and 3) the amounts of liver
RNA hybridizing to cloned P-450 cDNAs.

These studies establish that

P-450p is the predominant P-450 isozyme induced by clotrimazole,
miconazole, and ketoconazole.

Two of these drugs, clotrimazole and

miconazole also induced P-450b/e , whereas ketoconazole induced P-450j.
Differential increases in specifi c P-450 mRNAs and prote ins resulted
from treatment of rats with these imidazol e antifungal d rugs,
suggesting that multiple cellular events are involved t he ir mechanism
of P-450 induction.

In conclusion, expression of the P-450p family of

cytochromes P-450 in rat liver is under complex regulatory control and
is subject to modulation by clinically useful drugs.

© Keith A. Hostetler
All Rights Reserved

1988
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INTRODUCTION

Metabolism of foreign chemicals including drugs and other
xenobiotics, along with important endogenous compounds, is dependent on
catalysis by hemeproteins abundant in the endoplasmic reticulum of
hepatocytes collectively termed the cytochromes P-450 (Guengerich,
1979; Lu & West, 1980; Conney, 1982; and Coon & Koop, 1983).

The

unusually broad substrate specificity exhibited by these enzymes is
partially accounted for by the existence of multiple forms, or
isozymes, each encoded by a seperate gene (Adesnick & Atchison, 1985).
Another important feature which imparts versatility to this enzyme
system is that some, but not all isozymes of cytochrome P-450 are
inducible (Guengerich et al., 1982).

Thus, in response to a given

inducer, the concentration of one or more isozymes increases and then
returns to untreated levels upon clearance of the inducer.

Indeed, the

inducibility of xenobiotic metabolism was the basis for early
classification schemes of both cytochrome P-450 forms and chemicals
identified as P-450 inducers.

For example, isozymes of cytochrome

P-450 were initially believed to fall into one of three classes, a
"control" or untreated form, a form inducible by barbiturates such as
phenobarbital, or a form inducible by aromatic hydrocarbons such as
3-methylcholanthrene (Ryan, et al., 1979).
As methods for isolating and purifying isozymes of cytochrome
P-450 progressed, it became clear that rat liver contained more than
three distinct forms of cytochrome P-450.

Nevertheless, it remained

customary to classify newly identified inducing chemicals as being
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either "phenobarbital-like" or "3-methylcholanthrene-like ."

A third

prototype inducer, the catatoxic steroid pregnenolone-1 6a-carbonitrile
or PCN, was subsequently identified and shown to induce a form of P-450
distinct from those induced by either phenobarbital or 3-methylcholanthrene (Elshourbagy & Guzelian, 1980).

The major form of rat liver

cytochrome P-450 induced by PCN, by definition termed P-450p, has since
been the subject of extensive investigation and found to possess a
number of unique features among P-450 isozymes.

Studies of both

cultured hepatocytes and the living rat have revealed that expression
of P-450p is stimulated not only by PCN, but also by glucocorticoids,
barbiturates, organochlorine pesticides, halogenated biphenyls, and
macrolide antibiotics (Heuman et al., 1982; Schuetz et al., 1984;
Schuetz & Guzelian 1984; Schuetz et al., 1986; Wrighton et al. 1985a).
Moreover, functionally and structurally related cytochromes, or
homologues, have been identified in all species examined to date
including man (Wrighton et al., 1985b; Watkins et al. 1985).
A growing body of evidence has accumulated recently suggesting
that in rats, P-450p is only one member of a family of closely related
isozymes.

Indeed, it is clear that the cytochromes P-450 are encoded

by a superfamily of genes that can be divided into distinct families
based on genetic, regulatory, and structural similarities (Whitlock,
1986; Nebert et al., 1987).

In rat liver, one such family consists of

8 or more genes, several of which encode proteins that are inducible by
phenobarbital, including cytochromes P-450b and P-450e (Kumar &
Adesnick, 1983).

Likewise, 3-methylcholanthrene-inducible cytochromes

P-450c and P-450d, and ethanol-inducible cytochrome P-450j are
representatives of other distinct isozyme families (Ryan et al., 1979;
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Nebert et al., 1987).

Evidence for the existence of a "PCN family" of

cytochromes P-450 includes the observation that liver microsomes
isolated from dexamethasone-treated rabbits contain two immunoreactive
protein bands recognized by polyclonal antibodies raised against either
rat P-450p or the rabbit homologue P-450LM3c (Wrighton et al. 1985b).
In the same report, Northern blot analyses of liver RNA isolated from
PCN-treated rats revealed at least two
P-450p cDNA.

mRNA

species hybridizing to a

Southern blot analyses of either the rat or human genome

with the P-450p cDNA probe verified the existence of sufficient
hydridizable DNA to encode four or more P-450p-related genes (Watkins
et al., 1986).

Finally, Gonzalez and coworkers isolated and

characterized two nearly identical but distinct cDNAs from rats treated
with PCN (Gonzalez et al. 1985).

The deduced amino acid sequence of

one of these clones is identical with the N-terminal sequence of
P-450p.

Nevertheless, no single laboratory has succeeded in isolating

and purifying more than one steroid-inducible cytochrome P-450 from rat
liver.
Based on these observations, it was hypothesized that multiple
P-450p-related isozymes are expressed in rat liver.

Chapter 1 of this

thesis, entitled "Immunochemical Evidence for Multiple SteroidInducible Hepatic Cytochromes P-450 in the Rat," describes the
characterization of two highly specific monoclonal antibody probes
which react with two subtypes of structurally similar steroid-inducible
cytochromes P-450.

The data presented demonstrates that, although

these proteins share common structural features, they are under complex
and discoordinate regulatory control.

Expression of the P-450p family

of proteins is shown to be dependent not only upon recent exposure to a
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variety of inducing chemicals, but also upon gender.
Studies undertaken to isolate and purify from rat liver one or
more proteins distinct from but related to P-450p verified the
extensive structural and physical similarities among members of this
isozyme family.

Indeed, each purification study has resulted in the

co-purification of proteins from both subtypes of P-450p-like proteins.
Nevertheless, a new and unique class of chemical inducers of hepatic
cytochrome P-450 was identified in the course of screening novel
inducing compounds.

In Chapter 2, "Co-induction of Multiple Hepatic

Cytochrome P-450 Proteins and mRNAs in Rats Treated with Imidazole
Antimycotic Agents," three commonly used antifungal drugs are
characterized in terms of their differential effects on the expression
of three different families of hepatic cytochrome P-450.

Investigation

of the possible mechanism of induction of this class of compounds
suggests that effects on both RNA and protein metabolism are involved.

CHAPTER ONE

Irrununochemical Evidence for Multiple Steroid-Inducible
Hepatic Cytochromes P-450 in the Rat.
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ABSTRACT

It has been established that there are glucocorticoid-inducible
hepatic cytochromes P-450 in the rat (P-450p), the rabbit (LM3c), and
man (HLp) which share extensive structural, functional, and regulatory
features, and that in rats, P-450p may be a member of a family of
closely related cytochromes.

Immunochemical probes to P-450p were

prepared and a unique monoclonal antibody, lGB, was identified which
recognizes purified P-450p, but neither purified LM3c nor HLp upon
immunoblot analyses.

Similar analyses of liver microsomes from

untreated male rats revealed two lGB-reactive proteins, whereas liver
microsomes from untreated females contained none.

Another monoclonal

antibody, 13-7-10, reacted specifically with LM3c and HLp, but not with
P-450p.

A single 13-7-10-reactive microsomal protein was detected in

untreated male and female rats, the latter protein exhibiting a greater
apparent molecular weight.

lGB-reactive proteins were induced to the

greatest extent by triacetyloleandomycin, followed by dexamethasone,
chlordane,

pregnenolone-16~-carbonitrile,

chlorobiphenyl.

and 2,4,2' ,4'-tetra-

In contrast, 13-7-10-reactive proteins were most

strongly induced by dexamethasone, only moderately by triacetyloleandomycin and

pregnenolone-16~-carbonitrile,

all by 2,4,2' ,4'-tetrachlorobiphenyl.

weakly by chlordane and not at

In conclusion, the P-450p family

in rat liver consists of three or more proteins that are structurally
related and yet appear to be under distinct regulatory control.
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INTRODUCTION

The liver cytochromes P-450 are a superfamily of hemoproteins
located in the endoplasmic reticulum of the hepatocyte that play a
critical role in the biotransformation of a diverse array of endogenous
substances, such as steroid hormones, as well as xenobiotics, such as
drugs and carcinogens (Lu & West, 1979; Adesnik & Atchison, 1985).
Families of cytochrome P-450 proteins have been identified based on
their similarities in biochemical, immunochemical, and genetic
characteristics, including their responses to prototypic inducers.

For

example, P-450b and P-450e are immunochemically and structurally
similar hemoproteins that are coinduced in the liver of rats treated
with phenobarbital or phenobarbital-like inducers (Kumar et al., 1983;
Adesnik & Atchison, 1985).

Likewise, P-450c and P-450d are products of

homologous genes whose expression is stimulated by administration of
3-methylcholanthrene and other polycyclic aromatic hydrocarbons
(Adesnik & Atchison, 1985; Guengerich et al., 1982).
Several years ago, this laboratory identified a unique form of
cytochrome P-450 (Elshourbagy & Guzelian, 1980), now termed P-450p,
that is inducible by the synthetic steroid, pregnenolone-16acarboni trile (PCN) and by steroids of the glucocorticoid class such as
dexamethasone (Heuman et al., 1982; Schuetz et al., 1984).

Cytochrome

P-450p is structurally and functionally distinct from the
"phenobarbital-inducible" and "methylcholanthrene-inducible" forms of
cytochrome P-450, and yet P-450p is inducible by phenobarbital and
"phenobarbital-like" inducers (Guengerich et al., 1982; Heuman et al.,
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1982; Schuetz et al., 1986).

Macrolide antibiotics represent a third

group of compounds that induce P-450p (Wrighton et al., 1985a).
Cytochromes immunochemically and functionally related to P-450p have
been found in all species thus far examined (Wrighton et al., 1985b)
including P-450 LM3c in the rabbit and P-450 HLp in man (Watkins et
al., 1985).

Cytochrome P-450p may be involved in important

biotransformation reactions because it is conserved among mammalian
species and is regulated by an endogenous inducer (corticosterone)
(Schuetz & Guzelian, 1984).
It is now evident that P-450p is a representative of a multi-gene
cytochrome P-450 family.

Cloned cDNA's to P-450p hybridize to at least

two liver RNA species in PCN-treated rats (Wrighton et al., 1985b) and
to a sufficient amount of the rat genome to account for as many as five
P-450p-related genes (Molowa et al., 1986; Hardwick et al., 1983).
Until recently, the liver cytochromes isolated by others from PCNtreated rats [P-450PB/PCN-E (Guengerich et al., 1982) and P-4502a
(Waxman, 1986)] appeared to be the same as P-450p.

Gonzalez and

co-workers identified and isolated a PCN-inducible protein and
corresponding cDNA (P-450PCN1) (Gonzalez et al., 1985) apparently
identical to P-450p, and, in addition, have recently found a homologous
cDNA (P-450PCN2) that differs from P-450PCN1 in its deduced
NH 2 -terminal amino acid sequence (Gonzalez et al., 1986).

However, no

laboratory has isolated more than one P-450p-related protein from a
single species.

Some apparently homogeneous preparations may, in fact,

be mixtures of closely related polypeptides that cross-react with
polyclonal antibodies.
In the present study, monoclonal antibodies that recognize
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selectively individual PCN-inducible hepatic cytochromes P-450 were
prepared.

On the basis of analyses of rat liver microsomes with these

probes, it is concluded that rat liver contains multiple
immunochemically similar P-450p-related proteins that di splay separate
regulatory characteristics.
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MATERIALS

The polychlorinated and polybrominated biphenyl isomers,
2,4,2' ,4'-tetrachlorobiphenyl and 2,4,5,2' ,4' ,5'-hexabromobiphenyl,
were generous gifts from Dr. Stephen Safe and Dr. Stephen Aust,
respectively.

Chlordane and trans-nonachlor were gifts from Velsicol

(Chicago, IL).

Aroclor 1254 was obtained from Monsanto Co. (St. Louis,

MO) and SKF-525A was provided by Smith, Kline, and French
(Philadelphia, PA).

Triacetyloleandomycin was a gift of Pfizer

Laboratories (Brooklyn, NY) and PCN was provided by the Upjohn Co.
(Kalamazoo, MI).

Phenobarbital sodium was purchased fr om Amend Drug

and Chemical Co. (Irvington, NJ); isosafrole from Fluka (New York, NY);
HPLC-grade isopropanol from Burdick and Jackson (Muskegan, MI);
spironolactone, trans-stilbene oxide, chlorpromazine hydrochloride,
phenothiazine, diphenylhydantoin, metyrapone, dexamethasone,
clofibrate, and corn oil from Sigma (St. Louis, MO); peroxidaseconjugated anti-mouse IgG, rabbit anti-goat IgG, and goat peroxidase
anti-peroxidase from Miles Scientific (Elkhart, IN); ni t rocellulose
paper from Bio-Rad (Richmond, CA); and diaminobenzidine
tetrahydrochloride from Pfaltz and Bauer (Stamford, CT).
chemicals used were of reagent grade or better.

All other
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METHODS

Animals and Treatments.

Sprague-Dawley rats (100-150 g, Flow

Laboratories, Dublin, VA, USA) were housed in pairs in wire bottom
cages and given unlimited access to standard lab chow and water, unless
otherwise indicated.

All chemicals were dissolved in corn oil except

chlorpromazine, phenobarbital, and isopropanol, which were dissolved or
diluted in water, metyrapone, which was dissolved in 0.9% NaCl and
triacetyloleandomycin, which was added to powdered chow.

Single intra-

peritoneal injections of 2,4,2' , 4'-tetrachlorobiphenyl (500µrnoles/kg)
and 2,4,5,2' ,4' ,5'-hexabromobiphenyl (500µrnoles/kg ) were given four and
seven days, respectively, prior to microsome preparation.

A single

intraperitoneal injection was also given for Aroclor 1254 (300mg/kg)
four days prior to microsome preparation.

Daily intraperitoneal

injections were given for spironolactone (lOOmg/kg), trans-stilbene
oxide (300mg/kg), isosafrole (150mg/kg), chl orpromazine (40mg/kg),
phenothiazine (lOOmg/kg), PCN (300mg/kg), diphenylhydantoin (50mg/kg),
trans-nonachlor (46mg/kg), and chlordane (42mg/kg), each for four days
and SKF-525A (80mg/kg) and clofibrate (400mg/kg), each for three days.
Dexamethasone (300mg/kg) and isopropanol (15mmoles/kg) were given by
oral gavage daily for four days and for one day, respectively;
phenobarbital (0.1%) was administered in drinking water for 6 days;
triacetyloleandomycin (1% w/w) was fed in powdered chow for 10 days;
and metyrapone (500mg/kg) was given as a single intraperitoneal
injection one day prior to mi crosome preparation.
Each animal was fasted overnight and killed by decapitation.

The
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liver was perfused retrograde with cold phosphate buffered saline
(PBS), pH 7 .4, excised and homogenized, and microsomes were isolated by
differential centrifugation as previously described (Elshourbagy &
Guzelian, 1980).

The concentration of total CO-binding cytochrome P-

450 in the microsomal preparations and in the purified proteins was
determined by difference spectroscopy as described by Omura and Sato,
1964.

Microsomal protein concentrations were determined

colorometr i cal ly (Schacterle & Pollack, 1973).
Rat cytochrome P-450p (Wrighton et al., 1985a), rabbit cytochrome
LM3c (Koop et al., 1981), and human cytochrome HLp (Watkins et al.,
1985) were purified according to the indicated published procedures.
Preparation of Antibodies.

Five virus-free female Balb/c mice

(15-18 g, Charles River Labs, Raleigh, NC) were each injected
intraperitoneally with 50µg of purified P-450p in a 50mM potassium
phosphate, 50mM EDTA, 20% glycerol buffer combined with an equal volume
of Freund's complete adjuvant in a total volume of 0.2ml, followed 21
days later by a 20µg boost.

Six days after the boost, blood samples

from the mice were pooled and serum was prepared and assayed for the
presence of antibody by enzyme linked immunosorbent assay (ELISA).

A

final 20µg intravenous boost was performed 3 days prior to fusion.
Spleen cells from one immunized mouse were fused with P3-X63-Ag8
multiple myeloma cells and the resulting hybridoma were expanded in
vitro.
clones.

Limiting dilutions were carried out to isolate individual
These were tested for antibody production by ELISA, allowed to

expand, and then injected intraperitoneally into female Balb/c mice (5
X 10 6 cells per mouse) which had been primed with pristane (0.5ml
intraperitoneally) two weeks previously.

The resulting ascitic fluid
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was collected 9 to 14 days later, centrifuged to remove cells, and then
stored at -20° C.

The second monoclonal antibody used in these

studies, termed 13-7-10, was prepared by Dr. Kremers as described
elsewhere (Beaune et al., 1985).
A polyclonal anti-P-450p IgG raised in a goat was prepared as
previously described (Elshourbagy et al., 1981).
experiments absorbed anti-P-450p was used.

In some immunoblot

Briefly, liver microsomes

prepared from a 3-methylcholanthrene-treated male rat were solubilized
with cholate and bound to cyanogen bromide-activated Sepharose-4B (15mg
microsomal protein/ml Sepharose-4B) (Cautrecasas, 1970; March et al.,
1974).

The IgG fraction prepared from serum of a goat immunized with

P-450p was incubated overnight with the immobilized microsomes (lOOmg
IgG/ml of Sepharose-4B).

The unbound IgG was collected and subjected

to a second immunoabsorption step (25mg IgG/ml of Sepharose-4B) with
liver microsomes prepared from an untreated female rat bound to the
Sepharose matrix.
Immunoblot Analysis.

Quantitative analyses of immunoblots were

performed as described previously (Schuetz et al., 1984).

Briefly,

microsomal proteins were electrophoretically separated in 10% sodium
dodecylsulfate-polyacrylamide slab gels.

After the initial two hours

of electrophoresis, a different amount of purified protein standard was
added to each well.

Electrophoresis was then continued for an

additional one to two hours.

The resolved proteins were

electrophoretically transferred to nitrocellulose paper and nonspecific protein binding sites were blocked by an overnight incubation
of the nitrocellulose paper in PBS containing 3% bovine serum albumin
and 10% calf serum.

After a one hour exposure to the monoclonal

16
antibody, the blots were washed with cold PBS, incubated with
peroxidase-conjugated anti-mouse IgG for 30 minutes, and washed again
with PBS.

The immunoreactive proteins were visualized with the use of

diaminobenzidine in 0.006 % hydrogen peroxide.

The blots were scanned

with a Ziess densitometer to determine the integrated optical density of each protein band.

The amount of immunoreactive protein present in

each microsomal sample was calculated from the linear portion of a
standard curve derived from the densities of the purified proteins on
the same blot.

Qualitative immunoblots devel oped with goat anti-P-450p

IgG required a 30 minute exposure to rabbit anti-goat IgG and a 30
minute exposure to goat peroxidase anti-peroxidase wi th intervening PBS
washes.
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RESULTS AND DISCUSSION

Monoclonal antibody 1G8 was selected because this unique probe
reacted with purified rat P-450p on illUllunoblots but did not react with
the purified homologous proteins, rabbit cytochrome LM3 c (Wrighton et
al., 1985a) or human cytochrome HLp (Watkins et al., 1985) (Fig. 1).
Nevertheless, these three homologous proteins are illUllunochemically
related in being recognized by polyclonal antibodies raised against
either P-450p (Fig. 2, top) or LM3c (Watkins et al., 1985).

IllUl\unoblot

analyses of liver microsomes from untreated male rats developed with
1G8 revealed two narrowly separated proteins (Fig. 1).

The more slowly

migrating of the two 1G8-reactive proteins in untreated males had the
same mobility as did purified P-450p (Fig. 3).

In contrast, no

proteins were detected in liver microsomes isolated from untreated
female rats when immunoblotting was performed under conditions of
complete transfer (Schuetz et al., 1984) (Fig. 1).

When these

conditions were exceeded, trace amounts of 1G8-reactive protein were
observed indicative of very low level expression of P-450p in livers of
untreated female rats (see Appendix, figure 1).
Next, a second monoclonal antibody, 13-7-10, was characterized.
This antibody reacts specifically with HLp, a glucocorticoid-inducible
human liver cytochrome P-450 (Molowa et al., 1986).

The reactivity of

this monoclonal antibody was the opposite of 1G8 in that 13-7-10
specifically recognized purified rabbit LM3c and human HLp, but did not
recognize purified P-450p (Fig. 1).

Immunoblots of rat liver

microsomes developed with the 13-7-10 antibody revealed a reactive
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protein in both untreated males and untreated females (Fig. 1).

A

consistent finding was that the 13-7-10-reactive protein in females
migrated more slowly than did the 13-7-10-reactive protein in males
(Fig. 1).

Thus, two distinct 13-7-10-reactive proteins can be

distinguished on the basis of their mobilities and sex-specificities.
One or both of these proteins may be inducible because dexamethasone
treatment increased the amount of total 13-7-10-reactive microsomal
protein in female rats (Fig. 1).
The possibility that the microsomal proteins recognized by these
monoclonal antibodies are only coincidentally related to P-450p cannot
be excluded.

However, polyclonal antiserum directed against P-450p

reacted not only with all three purifi ed homologous proteins, P-450p,
LM3c, and HLp, but also with a pair of closely migrating, but separable
proteins, in rat liver microsomes from an untreated male rat and a
second pair in microsomes from an untreated female rat (Fig. 2).

When

the antiserum was absorbed first against immobilized rat liver
microsomes prepared from 3-methylcholanthrene-treated males and then
against untreated females, the resulting antibody still reacted
strongly with purified P-450p , but only weakly with LM3c and HLp and
not at all with microsomes from untreated female rats (Fig. 2).

Thus,

it appears that LM3c, HLp, and the 13-7-10-reactive protein present in
untreated female rats share one or more epitopes that are recognized by
neither the 1G8 monoclonal antibody nor the absorbed anti-P-450p IgG.
Finally, when portions of the same immunoblot were developed with
the anti-P-450p antiserum or with one of the two monoclonal antibodies,
the pair of !GS-reactive proteins in untreated male rats co-migrated
exactly with the proteins identified by the polyclonal antiserum (Fig.
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4).

Likewise, the proteins identified by the 13-7-10 monoclonal

antibody (one in untreated males and one in untreated females)
exhibited electrophoretic mobility identical to those recognized by the
polyclonal antiserum (Fig. 4).

Therefore, the proteins reacting with

the unabsorbed polyclonal antibody and the monoclonal antibodies are
probably the same.

There is no evidence to suggest that the faster

migrating female protein which was recognized only by the unabsorbed
polyclonal antibody is related to the P-450p family.

Therefore, it is

concluded that there are at least three related proteins expressed in
the livers of untreated rats:

P-450p, and the male- and

female-specific 13-7-10-reactive proteins.

It is possible that the

faster migrating of the two !GB-reactive proteins in untreated males
and the male-specific 13-7-10-reactive protein are the same, since both
proteins exhibit similar electrophoretic mobilities.
The next series of experiments investigated the effects of
treatment of female rats with inducers of P-450p on the amounts of lGBand 13-7-10-reactive proteins as determined by quantitative immunoblot
analyses of liver microsomes.

Because it was not possible to

sufficiently separate and individually quantitate the pairs of proteins
in induced rats, the results are expressed as the total lGB- or total
13-7-10-reactive proteins.

These studies utilized only one dose of

each compound at a level reported to be maximal for induction of
CO-binding hemoprotein.

TAO induced the !GB-reactive proteins to the

greatest extent (>300-fold increase over the minimum detectable value)
(Table 1).

This is consistent with the results of previous experiments

in which P-450p was quantitated by a polyclonal anti-P-450p IgG
preparation (Wrighton et al., 19B5b).

Other strong inducers of
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1G8-reactive proteins were dexamethasone (90-fold), chlordane (85fold), PCN (79-fold), trans-nonachlor (63-fold), SKF-525A (41-fold),
spironolactone (39-fold), metyrapone (32-fold), and 2,4,2' ,4'tetrachlorobiphenyl (20-fold) (Table 1).

In contrast, TAO only

moderately induced the 13-7-10-reactive proteins (21-fold increase)
compared to dexamethasone (49-fold increase) (Table 1).

Most striking,

however, was the relative lack of induction of 13-7-10-reactive
proteins by chlordane and trans-nonachlor, both of which were strong
inducers of the 1G8-reactive proteins (Table 1).

Similarly, SKF-525A,

spironolactone, and metyrapone were strong inducers of the 1G8-reactive
proteins but relatively poor inducers of the 13-7-10-reactive proteins
(Table 1).

In addition, 2,4,2' ,4'-tetrachlorobiphenyl only induced

1G8-reactive proteins (Table 1).

Weaker inducers of the 1G8-reactive

proteins included isosafrole, phenobarbital, trans-stilbene oxide, and
Aroclor 1254 (Table 1).

Each of these compounds was a super ior inducer

of the 1G8-reactive proteins as compared with the 13-7-10-reactive
proteins (Table 1). Phenothiazine, chlorpromazine, and isopropanol
exclusively induced the 1G8-reactive proteins whereas 2,4,5,2' ,4' ,5'hexabromobiphenyl, albeit a weak inducer, produced similar increases in
the 1G8- and 13-7-10-reactive proteins (Table 1). The responses of the
1G8- and 13-7-10-reactive proteins to diphenylhydantoin and clofibrate
were only marginal increases (Table 1).
This laboratory previously demonstrated that there is a striking,
qualitative difference in the regulatory control of P-450p-related
proteins between species (Wrighton et al., 1985b).

For example,

rifampicin, the most efficacious inducer of P-450 LM3c in the rabbit,
does not at all induce P-450p in the rat.

Conversely, PCN, an inducer
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of rat P-450p, is not an inducer of P-450 LM3c in the rabbit.

In this

study, using quantitative analyses, a striking difference was found in
the profile of induction among apparently related proteins within a
single species.

For example, the organochlorine pesticides chlordane

and trans-nonachlor, which strongly induced the 1G8-reactive proteins
were weak inducers of the 13-7-10-reactive proteins (Table 1).

Indeed,

2,4,2' ,4'-tetrachlorobiphenyl appeared to exclusively induce
1G8-reactive proteins (Table 1).

Although preferential induction of

cytochrome P-450 forms within a family has been demonstrated (Ryan et
al., 1980; Thomas et al., 1983), an example of induction of one (or
more) isozymes within an inducible family to the exclusion of other
family members has not been previously reported.

Thus it may be

concluded that although the 13-7-10-reactive proteins are related to
P-450p, they are subject to quantitatively and qualitatively distinct
control.
Gonzalez et

~

have reported differential regulation of two

mRNA's encoding members of the PCN family (Gonzalez et al., 1986).
They found that P-450PCN1 mRNA was undetectable in both untreated male
and female rats but was readily inducible by PCN and dexamethasone.
The homologous P-450PCN2 mRNA was present in untreated male and female
rats, was inducible by phenobarbital, but was refractory to induction
by PCN and dexamethasone.

The reported expression of P-450PCN2 mRNA

does not correspond to that of the immunoreactive proteins we have
described because none of the 1G8- or 13-7-10-reactive proteins are
present in both males and females and both groups of proteins are
readily inducible by PCN or dexamethasone (Table 1).

The resolution of

these discrepancies awaits more complete characterization of the
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multiple mRNA and protein species.
The immunoquantitation results provide a basis for ruling out the
possibility that the 13-7-10-reactive proteins might be previously
characterized rat liver cytochromes.

For example, cytochromes P-450b

and P-450e are elevated 20- to 30-fold in phenobarbital treated rats
(Waxman, 1986) which is inconsistent with the weak response of the
13-7-10-reactive proteins to phenobarbital (Table 1).

Likewise, it is

unlikely that 13-7-10 recognizes cytochromes P-450c and P-450d, which
are elevated 30-fold by Aroclor and 20-fold by isosafrole treatments,
respectively (Waxman, 1986) (see Table 1). Cytochrome P-450 PB-C (P-450
PB-1) (Guengerich et al., 1982; Waxman, 1986), which is induced by
neither PCN nor Aroclor (Guengerich et al., 1982) can also be ruled
out.

Finally, rat liver cytochromes P-450a, P-450f, P-450g, P-450h,

P-450i (Ryan et al., 1982; Ryan et al., 1984a; Ryan et al., 1984b), and
P-450 UT-H (Larrey et al., 1984) are proteins which are not significantly induced and actually may decrease following treatment with
phenobarbital, PCN, isosafrole, and Aroclor (Guengerich et al., 1982).
Vlasuk et al., 1982, used two dimensional gel electrophoresis to
tentatively identify as P-450p a polypeptide that was barely detectable
in untreated rats, was induced by PCN, isosafrole, SKF-525A, Aroclor
1254, and trans-stilbene oxide, but was not induced by chlordane.

This

laboratory recently identified a protein that had mobility on two
dimensional gel electrophoresis identical to that of P- 450p, was
recognized by polyclonal anti-P-450p IgG, and was induced by chlordane
(Schuetz et al., 1986).

Thus the polypeptide identified by Vlasuk and

co-workers may represent a distinct member of a PCN family (Schuetz et
al., 1986).

The exact relationship between the latter protein and the
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P-450p-related proteins we have identified in the present report
remains unclear since SKF-525A, isosafrole, and chlordane elevate the
13-7-10-reactive proteins to approximately the same extent (about 5fold above the minimum detectable amount) and Aroclor 1254 and
trans-stilbene oxide were only marginally efficacious inducers of
13-7-10-reactive proteins (Table 1 ).
It was observed that 13-7-10-reactive proteins were only weakly
induced by TAO (Table 1).

This might reflect differences in substrate

specificity of the 13-7-10-reactive proteins because the dramatic
induction of 1G8-reactive P-450p in TAO-treated rats is associated with
conversion of the drug by P-450p to a metabolite that binds P-450p
specifically (Wrighton et al., 1985a ).

In contrast, an agent has yet

to be identified that elevates 13-7-10-reactive proteins more than the
1G8-reactive proteins.

The most effective in this regard is

2,4,5,2' ,4' ,5'-hexabromobiphenyl, which elevated these proteins to a
similar extent.

Although no attempt was made to determine dose-

response relationships for the inducers, structural differences among
the polyhalogenated biphenyls may account for the apparent preferential
or selective induction of the two types of immunoreactive proteins
(Table 2). Indeed, this laboratory recently demonstrated that induction
of P-450p and P-450b/e by polychlorinated biphenyl isomers involves
different structure-activity relationships (Schuetz et al., 1986) .
In summary, based on immunoblot analyses of rat liver microsomes
developed with the antibody preparations described , at least two
heretofore unrecognized proteins distinct from but related to P-450p
have been identified.

Final proof that these proteins are products of

separate genes will require their purification, structural elucidation ,
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and assessment of their immunoreactivity.

Nevertheless, specific

monoclonal antibodies provide strong albeit indirect evidence to add to
the growing recognition that there is a family of "PCN
inducible-cytochromes P- 450" expr essed in rat liver.
appear to be discoordinately r egulated .

These proteins

They are under complex control

by factors associated with gender and are i nfluenced to different
extents by many structurally dissimilar exogenous compounds.

The

monoclonal antibodies described wi ll be most hel pful in eventually
achieving a complete structural desc ripti on of this unique family of
proteins and the mechanisms of the ir regulation.
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Table 1

Quantitation with monoclonals !GB and 13-7-10 of immunoreactive
cytochromes P-450 in rats treated with inducers.

Female rats were

treated and liver mic rosomes prepared and analyzed by quantitative
immunoblotting as described in Methods.

Results are expressed as

densitometric units per microgram of microsomal protein and the
corresponding fold increase over the lowest detectable valuea .

Shown

are the mean ± standard deviation of values obtained from three
individual rats.

Fold Increase

Inducer

lGB-reactive

13-7-10-reactive

Control
TAOb
DEX
CD
PCN

<0.007
2.230 ±
0.631 ±
0.594 ±
0.555 ±

562
121
.129
.049

319
90
85
79

<0.007
0.147 ±
0.341 ±
0.034 ±
0.147 ±

TNC
SKF
SLN
MTP
PCB

0.441
0.284
0.270
0.223
0.141

±
±
±
±
±

.065
.090
.071
.034
.040

63
41
39
32
20

ISF
PB
TSO
ARO
PTZ

0.110
0.096
0.081
0.078
0.050

±
±
±
±
±

.039
.021
.017
.022
.019

PBB
CLO
DPH
CPZ
ISO

0.040
0.039
0.022
0.019
0.012

±
±
±
±
±

.004
.008
.008
.006
.005

Fold Increase

.040
.063
.012
.029

21
49
5
21

0.028 ±
0.043 ±
0.044 ±
0.033 ±
<0.007

.004
.006
.012
.013

4.0
6.1
6.3
4.7

16
14
12
11
7

0.033 ±
0.049 ±
0.012 ±
0.009 ±
<0.007

.022
.018
.005
.022

4. 7
7.0
1. 7
1. 3

5.7
5.6
3.1
2.7
1. 7

0.027 ± .017
0.009 ± .002
0.009 ± .002
<0.007
<0.007

3.9
1. 3
1. 3
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Table 1 (cont'd.)

8

Detection of 1G8- and 13-7-10-reactive proteins in mic rosomes isolated
from untreated female rats requires analysis of sample s that exceed
the conditions established for quantitative electrophoretic transfer.
The above values for fold induction are calculated as i ncreases over
the lowest detectable value (.007 units/ ug) and thus underestimate the
magnitude of induction.

bAbbreviations used are:

TAO, triacetyloleandomycin; DEX, dexameth-

asone; CD, chlordane; PCN, pregnenolone-16a-carbonitrile; TCN, transnonachlor; SKF, SKF-525A; SLN, spironolactone; MTP, metyrapone; PCB,
2,4,2' ,4' ,-tetrachlorobiphenyl; !SF, isosafrole; PB, phenobarbital;
TSO, trans-stilbene oxide; ARO, arochlor; PTZ, phenothi azine; PBB,
2,4,5,2' ,4' ,5'-hexabromobiphenyl; CLO, clofibrate; DPH , diphenylhydantoin; CPZ, chlorpromazine; ISO, isopropanol.
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Figure 1.

Immunoblots of purified cytochromes P-450 and rat liver

microsomes.

Protein samples were electrophoretically resolved in

polyacrylamide slab gels, transferred to nitrocellulose paper, and
then developed with either monoclonal 1G8 (top) or 13-7-10
(bottom) as described in "Methods".

Shown are 1 µg each of

purified rat P-450p, rabbit LM3c, and human HLp; 50 µg of
microsomal protein from untreated rats, male (M) and female (F);
and 10 µg of microsomal protein from a dexamethasone-treated
female rat (DEX).

IG8

-

13-7-10

P-450p LM3c HLp

M

F

DEX
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Figure 2.

Specificity of anti-P-450p antibody before and after immuno-

absorption.

Purified cytochromes P-450 and rat liver microsomes

were analyzed by immunoblots, as described in "Methods", developed
with either polyclonal anti-P-450p serum (top) or anti-P-450p
antibody after 2X-immunoabsorption (bottom).

Shown are 0.5 µg

each of purified rabbit LM3c, human HLp and rat P-450p, and 50 µg
of microsomal protein from untreated male (M) and fema le (F) rats.

... --

Anti - P-450p
antiserum

2 x - absorbed
antibody

LM3c Hlp P-450p M

F
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Figure 3.

Relative electrophoretic mobility of 1G8-reactive microsomal

proteins with purified P-450p.

Immunoblot of puri f ied rat P-450p

(0.5 µg) and of microsomal proteins from an untreated male rat (M)
(50 µg) and from a dexamethasone-treated female rat (1 µg) (DEX)
developed wi th monoclonal antibody 1G8.

P-450p

M

DEX
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Figure 4.

Analyses of rat liver microsomes by immunoblots developed

with various antibodies.

Shown are microsomal protein samples (50

µg) from untreated male (M) and female (F) rats and microsomal
protein samples (5 µg) from a dexamethasone-treated female rat
(DEX).

Prior to development, the immunoblot was cut into strips

bisecting the lanes containing microsomal protein samples from
untreated rats.

Each strip was then developed with the indicated

antibody, as described in "Methods".

The dye front is shown to

demonstrate proper realignment of the nitrocellulose paper.

Anti-P-450p
Anti-P-450p
antiserum
13-7-10 antiserum

DEX F

M DEX F

M

IG8

DEX M DEX F

CHAPTER 'IWO

Co-induction of Multiple Hepatic
Cytochrome P-450 Proteins and rnRNAs in Rats Treated
With Imidazole Antimycotic Agents.
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ABSTRACT

To characterize the molecular basis by which imidazole antimycotic
drugs increase cytochrome P-450, the effects of treating rats with
clotrimazole, miconazole, or ketoconazole on expression of three forms
of the hepatic cytochromes P-450 (P-450p, P-450b/e , and P-450j) were
examined.

From measurements of liver microsomal catalytic activities

(demethylation of erythromycin, benzphetamine, or N-nitrosodimethylamine), microsomal content of immunoreactive cytochrome P-450 protein,
and the amounts of liver RNA hybridizing to cloned P-450 cDNAs, it was
established that the glucocorticoid-responsive P-450p is the form
predominantly induced by clotrimazole, miconazole and ketoconazole, to
as much as 382 times above control values.

The phenobarbital-

responsive cytochromes P-450b/e were induced modestly by clotrimazole
and miconazole, but not at all by ketoconazole.

In contrast, ethanol-

responsive P-450j was induced by ketoconazole but not by clotrimazole
or miconazole.

In several instances, treatment of rats with antifungal

drugs resulted in accumulation of P-450 protein which significantly
exeeded the corresponding increase in P-450 mRNA.

Specifically,

clotrimazole and ketoconazole disproportionately elevated P-450p and
P-450j protein, respectively, whereas P-450b/e protein accumulated in
excess of its mRNA following treatment with either clotrimazole or
miconazole.

From these results, it was concluded that imidazole

antifungal drugs differentially modulate the expression of at least
three distinct gene families of rat hepatic cytochromes P-450 by
seperate mechanisms involving accumulation of cytochromes P-450 mRNA
and hemeprotein.
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INTRODUCTION

Oxidative biotransformat i on of lipophilic compounds i s catal ysed
by membrane-bound hemeproteins abundant i n the endoplasmi c reticulum of
hepatocytes.

The existence of multipl e isozyme forms of these

cytochromes P-450 partially accounts f or the unusually broad substr ate
specificity exhibited by this enzyme syst em (Lu & West, 1980) .

Indeed,

the cytochromes P-450 are now recognized as a supe rfamily of isozymes
which can be subdivided into di s tinct f ami l i es according to common
structural, functional, or regulatory cha r act eri stics .

Many of these

isozymes are inducible by hormones , drugs, and other xenobiotics
(Whitlock, 1986).

For example, barbi turates such as phenobarbital,

polycyclic aromatic hydrocarbons such as f}-napthofl avone, glucocorticoids and anti-glucocorticoids such as pregnenol one-16a- ca rbonitrile
(PCN), and ketones and alcohols such as ethanol are exampl es of four
di fferent classes of agents that selectivel y i nduce one of f our
different families of cytochrome P-450.
Recently, N-substituted imidazole compounds have been shown to
increase the total amount of cytochrome P-450 in the live r (Lavri jsen
et al., 1986; Pershing et al . , 1986 ; Ritte r & Franklin, 1987).

Several

N-substituted imidazole derivatives a r e well known to be pot ent
inhibitors of oxidative metabol ism (Sheets et al . , 1986).

These

clinically useful antifungal agents i nterrupt synthesis of the major
fungal sterol, ergosterol, at the cyt ochrome P-450- mediated step of
lanosterol 14a-demethylation (Van den Bossche et al . , 1983).

When one

of these drugs, such as clotrimazole, miconazole , or ketoconazol e, is
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administered to rats, liver microsomal oxidation of typical cytochrome
P-450 substrates including erythromycin, aminopyrene, N,N-dimethylaniline, or p-nitroanisole is increased (Lavrijsen et al., 1986; Pershing
et al., 1986; Ritter & Franklin, 1987).

Analysis of the profile of

induced drug oxidizing activities suggests that clotrimazole may be a
steroid-like inducer of cytochrome P-450 (Pershing et al., 1986; Ritter
& Franklin, 1987), and miconazole may possess both steroid and

phenobarbital inducing characteristics (Lavrijsen et al., 1986; Ritter
& Franklin, 1987).

However, ketoconazole induces a dis t inct profile of

microsomal activities that do not resemble those from phenobarbital,
steroid, or methylcholanthrene-treated rats (Lavrijsen et al., 1986).
In the present study, the identity of the cytochrome P-450
isozymes regulated by these N-substituted imidazoles was investigated
not only by measuring microsomal drug oxidizing activities, but also by
analyzing liver microsomes on immunoblots developed with specific
antibodies directed against the major form(s) of cytochrome P-450
induced by glucocorticoids (P-450p), by phenobarbital (P-450b/ e), or by
ethanol (P-450j).

In addition, Northern blot analyses of liver RNA

were carried out to determine the amounts of mRNA hybridizable to
cloned cDNA probes to P-450p, P-450b/ e, and P-450j.

The results reveal

that P-450p is the major cytochrome induced by clotrimazole,
miconazole, and ketoconzole, and that the former two also induce
cytochrome P-450b/e, whereas only ketoconazole induced P-450j.
Moreover, there was a lack of proportionality between induction of
immunoreactive P-450 protein as compared to increases in hybridizable
P-450 mRNA suggesting that these antimycotics selectively induce some
cytochromes P-450 by effects on both mRNA and protein metabolism.
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MATERIALS

Triacetyloleandomycin (TAO) and ketocona zol e were gifts from
Pfizer Laboratories (Brooklyn, NY) and Janssen Pharrnaceutica
(Piscataway, NJ), respectively.

Erythromycin and d-benzphetarnine were

purchased from the Upjohn Co. (Kalamazoo, MI); phenobarbital sodium
from the Amend Drug and Chemical Co. (Irvington, NJ); clotrirnazole,
N-nitrosodimethylarnine, dexarnethasone, S-napthoflavone, and miconazole
nitrate from Sigma Chemical Co. (St. Louis, MO).

Crisco brand

cholesterol-free corn oil was purchased locally.

Nitrocellulose was

purchased from Bio-Rad (Richmond, CA); diarninobenzidine
tetrahydrochloride from Pfaltz & Bauer (Stamford, CT); goat peroxidase
anti-peroxidase from Miles Scientific (Elkhart, IN) and peroxidase
anti-mouse IgG, peroxidase anti-rabbit IgG, and rabbit anti-goat IgG
from ICN IrnrnunoBiologicals (Lisle, IL).
finest grade commercially available.

All other reagents were of the
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METHODS

Animals and treatments- Sprague-Dawley rats (175 - 225 grams, Flow
Labs, Dublin, VA)

were housed in pairs and given unlimited access to

food and water. Each compound was suspended in corn oil (except
phenobarbital, which was dissolved in 0.9% sodium chloride) and was
administered to female rats by oral gavage (except phenobarbital and
f3-napthoflavone, which were given by intraperitoneal injection).
Miconazole (150mg/kg), ketoconazole (150mg/kg), clotrimazole (lOOmg/kg
or 150mg/kg), phenobarbital (80mg/kg) and f3-napthoflavone (80mg/kg)
were each administered daily for three days.

Dexamethasone (300mg/kg ) ,

and TAO (480mg/kg) were given daily for three and five days,
respectively.

Vehicle-treated male and female rats were given corn oil

(lOml/kg) for three days.

Animals were fasted overnight and then

killed by decapitation 24 hours after the final treatment unless
otherwise noted.

Each liver was perfused with iced phosphate buffered

saline (PBS), pH 7.4, and then was excised and homogenized with a
motor-driven teflon pestle in a buffer containing lOOmM Tris (pH 7.4)
lOOmM KCl, lmM EDTA, and 20µM butylhydroxytoluene.

Microsomes were

isolated by differential centrifugation as previously described and
stored immediately at -70°C (Elshourbagy & Guzelian, 1980).

Total

CO-binding hemeprotein content of each microsomal sample was determined
as the dithionite reduced CO-difference spectrum (Omura & Sato, 1964 ) .
The sample cuvette was saturated with CO for 60 seconds and sequential
difference spectra were recorded until the absorbance at 450nm reached
a maximum.

Microsomes from TAO-treated rats we re decomplexed wi th
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K3 Fe(CN) 6 prior to the addition of carbon monoxide (Wrighton et al.,
1985a).

Microsomal protein concentrations were determined

colorimetrically (Schacterle & Pollack, 1973).
Isolation of Purified Proteins and Antibodies-

Rat liver

cytochromes P-450p (Wrighton et al., 1985b), P-450b (Waxman & Walsh,
1982), and P-450j (Ryan et al., 1985) were purified according to
indicated published procedures.

A monoclonal antibody directed against

purified P-450p was prepared and characterized as described (see
Chapter 1).

The polyclonal antibody directed against purified P-450b

was raised in a goat as described (Elshourbagy et al., 1981) and then
processed by sequential immunoabsorptions, first against liver
microsomes from 13-napthoflavone-treated rats, and then against
microsomes from untreated male rats.

The polyclonal antibody directed

against purified P-450j was raised in rabbits and characterized as
indicated (Thomas et al., 1987).
Microsomal N-demethylase Assays-

Microsomal benzphetamine and

N-nitrosodimethylamine N-demethylase activities were determined
essentially as described (Guengerich, 1982).

Briefly, 1.0 mg of

microsomal protein from control or treated rats was incubated at 37° C
in a lOOmM potassium phosphate buffer containing either 1.0 mM
d-benzphetamine or 1.0 mM N-nitrosodimethylamine along with
glucose-6-phosphate and glucose-6-phosphate dehydrogenase to generate
NADPH.

Erythromycin N-demethylase activity was measured as previously

reported (Wrighton et al., 1985a) with erythromycin present at a final
concentration of 0.4 mM and NADPH (40 mM final concentration) added
exogenously.

Enzymatic production of formaldehyde formed was

determined colorimetrically using a Nash reagent (Nash, 1953).
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Microsomes from TAO-treated rats were decomplexed with K Fe(CN)
3

6

prior

to the initiation of the N-demethylase reactions.
Immunoblot Analyses-

Liver microsomes were resolved in

polyacrylamide slab gels and blotted onto nitrocellulose filters under
conditions described previously (Schuetz et al., 1984; and see Chapter
1).

After an overnight incubation in blocking solution consisting of

PBS with 3% bovine serum albumin and 10 % calf serum, development of
each blot was initiated with a 60 minute exposure to the appropriate
antibody.

Exposure of blots to anti-P-450p antibody or anti-P-450j

antibody was followed by a 30 minute incubation with
peroxidase-conjugated anti-mouse or anti-rabbit IgG, respectively.
Immunoblots developed with anti-P-450b antibody required sequential 30
minute incubations with rabbit anti-goat IgG and peroxidase
anti-peroxidase.

goat

Nitrocellulose filters were washed thoroughly with

PBS between successive antibody incubations.

Immunoreactive proteins

were visualized with N,N-diaminobenzidine in 0.006% H2 0 2

•

Quantitative

immunoblot analyses included the appropriate purified cytochrome P-450
(0.2 to 2.0 pmoles for purified P-450p and P-450b, and 1.0 to 6.0
pmoles for P-450j).

The integrated density of each immunoreactive band

for both standards and samples was quantitated with a Ze iss
densitometer as described (see Chapter 1).
Isolation and Analyses of RNA-

The P-450p (Wrighton et al.,

1985a), P-450b/e (Adesnik et al., 1981 ), and P-450j (Wrighton et al.,
1986) cDNA probes were isolated and chacterized in the indicated
references.

Total liver RNA from control or treated rats was isolated

from a 0.5 g portion of liver using the guanidine isothiocyanate method
(Elshourbagy et al., 1981; Deeley et al., 1977) .

Northern blot
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analyses were carried out as previously described (Wrighton et al.,
1985a).

Briefly, aliquots of RNA from each animal were resolved by

electrophoresis in agarose gels and then transferred to nitrocellulose
filters.

Each filter was baked under vacuum, prehybridized, and then

incubated in a hybridization solution containing
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P-labelled cDNA

probes as described previously (Schuetz et al., 1986).

Hybridization

of the labelled cDNA probes to filter-bound RNA was visualized by
autoradiography.

Identical hybridization conditions we r e utilized for

quantitation, except that RNA samples were diluted and applied directly
to nitrocellulose filters using a Schleicher and Schuell slot blot
apparatus according to the manufacturers specifications.

For each

treatment group, a range of RNA (from 0.05 to 30µg) was analyzed.
Autoradiography and scanning densitometry revealed a linear
relationship between optical density of the hybridizati on signal and
the amount of RNA analyzed.

A slope was determined for each animal and

was compared to the slope representing hybridizable

mRNA

from a control

female rat analyzed on the same filter.
Statistical methods-

Two-tailed student t tests we re performed on

unpaired sample means and the significance determi ned at two levels ,
p

~

0.01 and p

~

0.05.
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RESULTS

Effect of Treatments on Total CO-binding Cytochrome P-450Clotrimazole, miconazole and ketoconazole have each been identified as
inducers of total spectrally determined cytochrome P-450 in previous
reports (Lavrijsen et al., 1986; Ritter & Franklin, 1987) , although the
maximum tolerated dose of each of these compounds has not been
reported.

Preliminary studies demonstrated that clotrimazole

administered at 150mg/kg daily for three days produced a remarkable
increase (5.1-fold) in total CO-binding cytochrome P-450 (Figure 1).
This induction was even greater than that produced by triacetyloleandomycin (TAO) (Figure 1), a macrolide antibiotic inducer of P-450p which,
until now, was the most efficacious inducer of rat live r cytochrome
P-450 previously reported (Wrighton et al., 1985b; and Chapter 1).
Treatment of rats with the maximum tolerated dose (150mg/kg) of
ketoconazole or miconazole increased cytochrome P-450 over control
values by 1.6 and 1.8-fold, respectively, similar to increases
following treatment with dexamethasone (2.3-fold) or phenobarbital
(1.9-fold) (Figure 1).

It was observed that only 2 to 3 minutes was

required to acheive the peak absorbance at 450nm after CO saturation of
the sample cuvette, except for samples from clotrimazole-treated rats,
which required 16 to 24 minutes (see Appendix, figure 2).

Others have

reported a slowly developing difference spectrum, indicative of
competition between CO and a compound tightly bound to heme (Ritter &
Franklin, 1987; Yoshida & Aoyama, 1987).

To test this idea, female

rats were treated with a reduced dose of clotrimazole (lOOmg/kg daily
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for 3 days) and liver microsomes were isolated 42 hours (instead of the
routine 24 hours) after the final clotrimazole treatment .

The extent

of induction of total CO-binding cytochrome P-450 in these microsomes
was unchanged with the use of this prot ocol (data not shown).
Nevertheless, despite the extended delay between the final clotrimazole
treatment and microsome isolation, the putative residual competitor was
still present, as evidenced by a requirement of 6 to 12 minutes before
the CO-difference spectrum to reached a maximum.
Effect of Treatments on Microsomal N-demethylase ActivitiesErythromycin N-demethylase (ERMD), a microsomal function known to be
catalysed by P-450p (Wrighton et al., 1985b) was increased 7.3-fold
above control values

by clotrimazole treatment (Table 1 ).

To reduce

the interference by a residual competitor, (see preceeding paragraph),
microsomes were isolated 42 hours after the last clotrimazole treatment
for ERMD measurements.

The magnitude of induction of ERMD by

clotrimazole was similar to that produced by TAO and dexamethasone, two
known inducers of P-450p (Table 1) (Wrighton et al., 1985a; see also
Chapter 1).

Miconazole treatment elevated ERMD activity to a lesser

degree (2.2-fold, Table 1) whereas ketoconazole failed to induce ERMD
activity (Table 1).

The lack of detectable ERMD activity in

microsomes isolated from ketoconazole-treated rats may be the result of
low amounts of residual drug inhibiting P-450p as was obsersved with
microsomes isolated 24 hours after the last clotrimazole treatment (see
Appendix, figure 2).
Microsomal benzphetamine N-demethylase (BNZD) activity, a marker
of phenobarbital-responsive cytochromes P-450b/ e (Guengerich et al.,
1982), was stimulated to the greatest extent by treatment with
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phenobarbital (5 .8-fold ) or miconazole (5 .1-fold, Table 1 ) .
Clotrimazole also significantly stimulated BNZD activity ( 3.2-fold )
whereas ketoconazole produced only a marginal increase (1.3-fold ) in
this activity (Table 1).
N-nitrosodimethylamine (NDMA) N-demethylase activity, a marker of
the ethanol-inducible rat cytochrome P-450j (Yang et a l ., 1985; Ryan et
al., 1986; Levin et al., 1986 ) gave more variable results, but was
increased the greatest by miconazole ( 3 times the value in female
controls, Table 1), slightly by ketoconazole and not significantly by
clotrimazole (Table 1 ) .
Identification and Quantitation of Immunoreactive eytochromes
P-450- Representative qualitative immunoblots of liver microsomes fr om
control and induced rats probed with antibodies raised against purified
cytochromes P-450p, P-450b, and P-450j are shown in Figure 2.

As

reported previously, the anti-P-450p monoclonal antibody 1G8 reacts
with P-450p and with a faster-mi grating protein expresssed in untreated
male rats (see Chapter 1).

The same bands are observed in microsomes

from dexamethasone-treated female rats (Figure 3 ) .

The

faster-migrating protein expressed in untreated male rats and in
induced female rats represents a P-450p-related protein ( see Chapter 1 )
which has not yet been isolated and characterized .

The present studies

revealed that imidazole drugs induce two 1G8-reactive proteins as does
dexamethasone (Figure 3).

The strong inducti on of the upper protein

band precluded acceptable resolution and seperate densitometric
quantitation of the t wo immunoreactive proteins.

The t wo bands

measured as total anti-P-450p-reactive microsomal protein were markedly
inceased (more than 380-fold over control values ) by clot rimazole
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(Table 2).

Clotrimazole induced imrnunoreactive P-450p in excess of

that induced by TAO (221-fold, Table 2).

Miconazole and ketoconazole

were less effective inducers of imrnunoreactive P-450p (52- and 54-fold,
respectively) and were intermediate between dexamethasone (124-fold )
and phenobarbital (26-fold, Table 2).

The inductions of imrnunoreactive

P-450p protein were accompanied by increases in ERMD activity except
for microsomes from ketoconazole-treated rats in which ERMD activity
remained unchanged from control values (Tables 1 and 2).
The same liver microsomal samples were quantitatively analysed on
imrnunoblots developed with anti-P-450b or anti-P-450j antibodies (Table
2).

Miconazole and clotrimazole induced imrnunoreactive P-450b/ e by 86-

and 102-fold, respectively, whereas ketoconazole did not induce
P-450b/e protein (Figure 2, Table 2 ) .

In contrast, among all the

agents tested, only ketoconazole increased (2-fold) the level of
immunodetectable P-450j (Table 2).

NDMA N-demethylase activity was

increased to a similar extent in the ketoconazole microsomes (Tables 1
and 2).

In contrast, miconazole treatment increased NDMA N-demethylase

activity 3-fold even though immunoreactive P-4 50j protein was not
elevated (Table 2).
Analyses of Cytochrome P-450 mRNA-

Representative Northern blots

of liver RNA isolated from control and treated rats revealed
differential hybridization signals depending upon which of the three
P-450 cDNA probes was employed (Figure 4).

The results of the

quantitation studies, summarized in Table 3, showed that clotrimazole
treatment increased hybridizable P-450p mRNA 93-fold over the control
value, a rise much less than the corresponding 382-fold increase in
immunoreactive P-450p protein (Tables 2 and 3).

Similarly, TAO
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produced a disproportionate increase in immunoreactive P-450p protein
(221-fold) as compared to hybridizable P-450p mRNA (45-fold, Tables 2
and 3).

In contrast, miconazole, ketoconazole, dexamethasone and

phenobarbital each produced nearly identical increases over control
values in P-450p immunoreactive protein and in hybridizable mRNA
(Tables 2 and 3).
Less than proportionate increases in hybridizable P-450b/e mRNA as
compared to total immunoreactive P-450b/e protein were also apparent
following clotrimazole, miconazole, phenobarbital, or dexamethasone
treatments (Tables 2 and 3).

As expected, ketoconazole, which failed

to increase either BNZD activity or immunoreactive P-450b/e protein,
produced no change in hybridizable P-450b/e mRNA (Table 3).
None of the agents tested increased hybridizable P-450j mRNA
including ketoconazole, the only imidazole which induced immunoreactive
P-450j protein (Table 3).

The latter observation is consistent with

reports that treatment of rats with pyrazole, acetone, or
4-methylpyrazole increases immunodetectable P-450j protein and NOMA
N-demethylase activity but does not incresase P-450j mRNA (Wrighton et
al., 1986; Song et al., 1986).
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DISCUSSION

The results of this study demonstrate that N-substituted
imidazoles including clotrimazole, miconazole and ketoconazole,
represent a new class of inducers of the glucocorticoid-responsive
family (Nebert et al., 1987) of hepatic cytochromes P-450 .

These

antifungal drugs increased ERMD, an activity linked to P-450p, induced
one or more immunoreactive P-450p proteins, and increased the amount of
liver

mRNA

hybridizing to a P-450p cDNA probe.

Indeed, clotrimazole

now supplants TAO as the most effective known inducer of total
CO-binding hemeprotein and of P-450p (Wrighton et al., 1985b; see also
Chapter 1).

Exact identification of the subtypes of P- 450p-re lated

protein(s) induced by these antifungal drugs will require further
study.
The cytochrome P-450 inducing properties of the antimycotic drugs
are not limited to members of the P-450p family.

Catalytic,

immunochemical and cDNA hybridization studies demonstrated that
clotrimazole and miconazole, but not ketoconazole, are also effective
inducers of the phenobarbital-inducible cytochromes P-450b/e.

Indeed,

at the doses administered, both miconazole and clot rimazol e proved to
be as effective as was phenobarbital in increasing total P-450b/e
immunoreactive protein and hybridizable P-450b/e

mRNA

(Tables 2 and 3).

Clotrimazole and miconazole can be grouped along with compounds such as
chlordane, transnonaclor, halogenated biphenyls, and phenoarbital as
shared inducers of the steroid- and phenobarbital-responsive
cytochromes P-450 and provide further evidence that, in rat liver,
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these two distinct families exhibit overlapping regulatory
characteristics.

This is in contrast to other families of cytochrome

P-450, such as the aromatic hydrocarbon-inducible isozymes which
exhibit stricter structure-acitvity requirements for inducibility and
less overlap with inducers of other families of cytochrome P-450.
Several years ago, this laboratory investigated the mechanism
underlying the dramatic induction of cytochrome P-450p by the macrolide
antibiotic, TAO and found that in both hepatocyte cultures and in
living rats, this drug selectively prolongs the half-li fe of P-450p
(Watkins et al., 1986).

Thus, TAO treatment results in a marked

accumulation of P-450p protein while P-450p mRNA is inc reased only
slightly (Wrighton et al., 1985b; Watkins et al., 1986).

In the

present studies, the administration of clotrimazole to rats also
produced a disproportionately large increase in P-450p protein relative
to the rise in hybridizable P-450p mRNA (Tables 2 and 3).

Thus, it

seems likely that clotrimazole, like TAO, inhibits the rate of
degradation of P-450p.

TAO is known to be converted by P-450p to a

metabolite that then binds tightly to P-450p and inhibits its further
catalytic activity (Wrighton et al., 1985; Pessayre et al., 1981).
However, clotrimazole does not appear to form such a spectrally
detectable complex with P-450p (Pershing et al., 1986).

In this

regard, clotrimazole resembles other types of P-450p inducers such as
clordane or trans-nonaclor which increase the accumulation of P-450p
protein to a greater extent than they increase its rate of de nova
synthesis and yet do not form a stable metabolite complex with P-450p
(Schuetz et al., 1986).

In contrast to clotrimazole, miconazole and

ketoconazole increased P-450p protein and mRNA to similar extents as

50
did dexamethasone and phenobartibal (Tables 2 and 3).

These findings

suggest that the imidazole antifungal drugs may be useful probes for
further study of the control of P-450p turnover.
A notable discrepancy became apparent when the magnitude of
induction of P-450p mRNA and protein by dexamethasone observed in this
study was compared with that reported earlier by Simmons and coworkers.
These investigators found that a single dexamethasone injection
increased hybridization of cytoplasmic poly(A) mRNA to a P-450PCN cDNA
probe a maximum of 18-fold over control values, whereas chronic
dexamethasone administration (80mg/kg daily for 4 days) elevated
irnrnunodetectable P-450PCN protein only 4-fold (Simmons et al., 1987).
In contrast, in the present study, dexamethasone was found to induce
P-450p mRNA and protein 141-fold and 124-fold, respectively (Tables 2
and 3).

It is possible that differences in gender of rats treated,

doses and routes of administration of the steroid, methods of
immunoquantitation, and specificities of antibodies utilized may
account for the observed discrepancies.
As was the case with cytochrome P-450p, measurements of P-450b/e
protein and mRNA following treatments with several inducers also
revealed accumulation of immunoreactive protein in excess of
hybridizable mRNA (Tables 2 and 3).

In this regard, the imidazoles

miconazole and clotrirnazole produced the greatest discrepancy,
elevating P-450b/e protein 5.4 and 3.6 times more than hybridizable
P-450b/e mRNA, respectively, as derived from data presented in Tables 2
and 3.

Less dramatic differences in accumulation of P-450b/e protein

and mRNA resulted from phenobarbital or dexamethasone t r eatments (a
ratio of increase in P-450b/e protein to mRNA of 2.3 and 2.2,
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respectively).

It is noteworthy that Sirrunons and coworkers found a 10-

to 12-fold increase in hybridizable P-450b/e mRNA following
dexamethasone treatment, nearly identical to the increase observed in
the present study (Table 3, Sirrunons et al., 1987 ) .

Moreove r, in this

same report, these investigators suggested the possible existence of a
steroid-inducible P-450b-related protein (or proteins) that have not
yet been identified (Sirrunons et al., 1987).

Indeed, in the present

studies, it was observed that dexamethasone induced a qualitativly
distinct pattern of microsomal proteins recognized by the anti-P-450b
antibody.

As shown in Figure 2, the major anti-P-450b-reactive band in

microsomes isolated from dexamethasone-treated rats exhibits a slightly
greater apparent molecular weight than the major protein band induced
by phenobarbital, miconazole, or cl otrimazole.

Thus , the value

reported for total irrununoreactive P-450b/e in microsomes from
dexamethasone-treated rats reflects the presence of not only
cytochromes P-450b and P-450e, but other immunochemically related
proteins.
The expression of cytochrome P-450j, another isozyme representing
yet another cytochrome P-450 family, was stimulated by ket oconazole,
but not by either clotrimazole or miconazole.

Induction of P-450j by

ketoconazole was evidenced by increases in both NDMA N-demethylase
activity and immunodetectable P-450j, whereas levels of hybridi zable
P-450j mRNA were unchanged by ketoconazole treatment (Tables 1, 2 and
3).

Thus, ketoconazole, like other inducers of P-450j, appears to

affect the expression of this isozyme by post-translational mechanisms
(Wrighton et al., 1986; Song et al., 1986).

Moreover, it can be

reasonably concluded t hat, as a class of P-450 inducers in the rat, the
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N-substituted imidazoles are apparently capable of regulating at least
three families of cytochrome P-450 isozymes by multiple mechanisms, one
of which involves altered protein turnover.
In summary, the present findings add to the growing body of
evidence that N-substituted imidazoles represent a unique and important
class of agents which have multiple effects on the expression of rat
hepatic cytochromes P-450.

These drugs will undoubtedly serve as

useful as tools in the ongoing investigation of the molecular
mechanisms involved in the regulation of the hepatic cytochromes P-450.
Obviously, the doses of clotrimazole, miconazole and ketoconazole
administered in this study far exceed clinically revelant doses of
these compounds.

Nevertheless, it is clear that the potential exists

for significant alterations in human metabolism during antimycotic
therapy.

Indeed, there have been numerous reports of ketoconazole-

associated hepatic injury (Stricker et al., 1986).

Recently, in

addition to its use as an antifungal agent, this drug has been utilized
as an inhibitor of steroid synthesis (Sonino, 1987) further emphasizing
the importance of identifying the mechanisms by which ketoconazole and
structurally similar compounds modulate the expression and functon of
cytochromes P-450.

Because clotrimazole and miconazole are primarily

used topically thereby limiting systemic absorption, less has been
reported about their effects on human metabolism.

In conclusion, this

study indicates that newly developed orally-administered N-substituted
antimycotics should be carefully examined as possible modulators of
oxidative metabolism in man .
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hours after the last treatment. Microsomes from TAO-treated rats were decomplexed with K3 FeCN6 prior
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vehicle-treated female rats.

±
±
±
±

0.029•
0.035 ± 0.011
0.040 ± 0.011
0. 029•

0.008
0. 988
0.211
1 . 764

0. 006.
( 1)
0.138 ± 0.068 (23)
0.476 ± 0.132 (79)
0.019 ± 0.013 ( 3)

13--napthoflavone
Dexamethasone
Phenobarbital
TAO

0.031 ± 0.004 (0 .69 )
0 .039 + 0.013 (0 . 87)
0.095b- ± 0.011 (2 .10)

0.514 ± 0.190 (86)
0 . 613 ± 0.125 (102)
0 . 007 ± 0.002 ( 1)

3.054 ± 0.423 (382)
0.414 ± 0.116 (52)
0. 429 ± 0 .150 (54)

Clotrimazol e
Miconazole
Ketocanazole

(1)
(0.76)

0.045 ± 0.016
0.034 ± 0.004

0. 006·
0. 005•

0.008 ± 0.001 ( 1 )
0.013 ± 0.002 ( 1.6 )

vehicle (F)
vehicle (M)

( 1)
(1)

Anti-P-450j

Anti-P-450 b/e

Anti- P-450p

Treatment

QUANTITATION OF IMMUNOREACTIVE CYTOCHROMES P-450 IN
LIVER MICROSOMES FROM RATS TREATED WITH INDUCERS

TABLE 2

U1

°"

1.6
140.8
28.l
44.8
±
±
±
+

0.1
17 .8
3.4
3.6

x

0.5
10.l
36.0
3.7
±
±
±
-+

0.1
3.5
1.9
0.6

23.9 ± 0.9
18.8 ± 1.9
0.9 ± 0.3

0.9 ± 0.2

control ± SD

P-450b/e

x

0.5
0.7
1.0
0.7

±
±
±
-+

0.1
0.1
0.2
0.1

0.7 ± 0.1
1.0 ± 0.3
0.7 ± 0.2

0.9 ± 0.2

control ± SD

P-450j

Identical samples of total liver RNA analyzed in Figure 4 were subjected to slot blot analyses as
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Figure 1.

Total Spectral P-450 in Liver Microsomes.

Rats were treated

with inducers (BNF, 13-napthoflavone; DEX, dexamethasone; PB,
phenobarbital; TAO, triacetylolandomycin; CTZ, clot rimazole; MCZ ,
miconazole; KCZ, ketoconazole) or vehicle (F, fema l e;
described in Methods.

M, male) as

Liver microsomes were isolated by

differential centrifugation and total spectral P-4 50 was
determined by carbonyl-reduced difference spectroscopy .
Sequential spectra were recorded until the absorbance maxium at
450nm reach a maximum.

In the case of microsomes from TAO-treated

rats, K3 Fe(CN) 6 was added to a final concentration of 20 µM three
minutes prior to carbon monoxide.

Shown are the mean+ the

standard deviation of values from five individual rats .
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Figure 2.

Immunoblot Analysis of Liver Microsomes Developed with

Anti-P-450p.

Microsomal samples were resolved electrophoretically

in 10% SDS-polyacrylamide slab ge ls and then trans f erred to
nitrocellulose filters which were subsequently incubated with
anti-P-450p antibody. Immunoreactive protein bands were visuali zed
with diaminobenzidine.

Shown are microsomal sampl e s from a

vehicle-treated male rat (M, 50 µg protein) and mi c rosomes
isolated f rom female rats treated with either dexamethasone (DEX,
3µg protein), clotrimazole (CTZ , l.5µg protein), mi conazole (MCZ,
15µg protein) or ketoconazol e (KCZ, lOµg protein).

Also shown is

1.0 pmole of purified P-450p.

M

DEX

CTZ

MCZ

KCZ P- 4 50P
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Figure 3.

Irnmunoblot Analyses of Liver Microsomes.

Microsomal samples

from control or induced rats containing the indicated protein
quantities were electrophoresed, blotted, and then developed with
the indicated antibodies as described in Methods.

Also included

are purified cytochromes P-450p (top panel), P-450b (middle panel)
and P-450j (bottom panel).
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Figure 4.

Northern Blot Analyses of Hybridizable P-450 mRNA.

Total

liver RNA isolated from rats treated as outlined in figure 1 was
subjected to electrophoresis in agarose gels, transferred to
nitrocellulose filters and then hybridized with the indicated
32

P-labelled cDNA probe as described in Methods.

Hybridizable

P-450 mRNA was visualized by autoradiography.
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DISCUSSION

Since the isolation and purification of the major rat liver
cytochrome induced by PCN reported by this laboratory (Elshourbagy &
Guzelian, 1980), there has been extensive effort here and elsewhere to
further characterize this protein and the mechanisms involved in its
regulation.

Strong, albeit indi rect evidence suggesting the existence

of a "PCN family" of cytochromes in the rat, analogous to other
families of inducible P-450 isozymes, prompted the development of a
battery of immunochemical probes to carry out more definitive
investigations.

The results from these studies further establish that

the P-450p family is unique among the families of rat liver cytochromes
P-450 identified.
On the basis of immunochemical evidence generated with highly
specific monoclonal antibodies, it was concluded that at least three
(and possibly four) P-450p-related forms are expressed in the liver of
untreated rats.

Both male-specifi c and female-specific members exist

among these "control" forms of the P-450p family, an unusual feature
among inducible cytochromes P-450 (Waxman, 1986).

Moreove r , expression

of subtypes of P-450p-related proteins is differentially affected by
xenobiotic inducers.

In contrast, other inducible families of P-450,

such as cytochromes P-450b and P-450e and cytochromes P-450c and P-450d
rise in parallel in response t o phenobarbital and aromatic
hydrocarbons, respectively (Adesnick & Atchison, 1985; Whitlock, 1986).
Another striking feature of the P-450p family is the lack of
structural similarity among chemical inducers that have been
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identified.

These include steroids, barbiturates , halogenated

biphenyls, organochlorine pesticides, mac rolide antibiotics, and most
recently, imidazole antimycotic agents.

From this observation, it is

clear that the regulation of this family of isozymes is complex.
Indeed, multiple mechanisms have been impli cated in the induction of
the major form, P-450p.

Hormonal regulation accounts f or the

male-specific expression of P-450p in untreated rats (Waxman et al . ,
1985).

Induction of P-450p by steroids clearly involves factors

dissociated from the glucocorti coid receptor and possibly invol ves a
unique "PCN receptor" (Scheutz & Guzelian, 1984).

It

i s known that PCN

stimulates the rate of transcription of the gene encoding P-450PCN
(Hardwick et al., 1983) presumably t he same protein as P-450p
(Hostetler et al., 1987).

It is noteworthy that dexamethasone , a

strong inducer of both subtypes of t he P-450p family, induces other
P-450 isozymes, most notably P-450b/e , by prolonging the half-life or
"stabilizing" messenger RNA (Simmons et al., 1987) .

Thus, it is

possible that a single agent, dexamethasone, may regul ate P-4 50p
expression via multiple mechanisms.
Another previously identified mode of induction of P-450p involves
the selective prolongation of the half-life of this isozyme which
occurs following administration of t riacetyloleandomyci n .

The result

is a profound accumulation of P-450 protein, far in excess of the
corresponding inc rease in P-450p mRNA (Watkins et al. 1986).

In the

present studies, a newly identified inducer of P-450p was found to
markedly induce P-450p to a similar or even greater extent than does
triacetyloleandomycin.

Moreover , the disproportionate accumulation of

P- 450p protein relative to mRNA following clotrimazole t reatment
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strongly suggests t hat this drug also significantly retards the rate of
P-450p catabolism. It is noteworthy that neither of the structural
analogs miconazole nor ketoconazole share this apparent stabilizing
effect on P-450p.

Nevertheless, both clotrimazole and miconazole

induce P-450b/ e protein in excess of the corresponding mRNAs, and
likewise, ketoconazole increases P-450j protein but causes no increase
in the level of P-450j mRNA.

These observations by no means prove, but

are consistent with the testable hypothesis that these imidazole
antifungal drugs regulate multiple P-450 isozymes in a selective
fashion by altering rates of hemeprotein turnover.
Recent observatons in this laboratory suggest that the P-450p
homologue in man, cytochrome HLp, is also a member of a multigene
family.

Thus, glucocorticoid-responsive cytochrome(s) P-450 in human

liver not only serve as a useful model for further studies of the
mechanisms of eucaryotic gene regulation, but also represent an
important enzyme system prone to modulation by commonly used drugs
including glucocorticoids, barbiturates, macrolide antibiotics, and
imidazole antimycotic agents.

Continued investigation i n this area

will undoubtedly enhance basic understanding of this important enzyme
system as well as provide a basis for rational and effective drug
therapy.
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APPENDIX
Appendix Figure 1.
rats.

Low level expresssion of P-450p in untreated female

Shown is an imrnunoblot of 50µg of microsomal protein from

an untreated female rat (F) and 4.0µg from a clotrimazole-treated
female rat (CTZ) developed with anti-P-450p monoclonal antibody
1G8.

As described in Chapter 1, the detection of imrnunoreactive

P-450p in microsomes from untreated female rats requires the
analysis of quanitities of protein which exceed the limit
established for quantitative electrophoretic transfer, which is
35µg.

F CTZ
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Appendix Figure 2.

Time course for saturation of

co binding to

cytochrome P-450 in liver microsomes isolated from rats treated
with clotrimazole at a dose of 150mg/kg daily for 3 days.
Microsomes were isolated 24 hours after the last clotrimazole
treatment.

Microsomal suspensions were diluted to 1 . 0mg/ ml,

reduced with sodium dithionite, and then split between sample and
reference cuvettes of an Aminco DW-2a dual beam spectrophotometer.
After a baseline recording, CO was bubbled through the sample
cuvette for 60 seconds and then successive difference spectra
between 360 and 510nm were recorded at the indicated time points.
As described in Chapter 2, the slowly developing CO-difference
spectrum is indicative of competition between CO and a compound
tightly bound to heme.
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